273 related articles for article (PubMed ID: 29870778)
1. Locomotor activity, emotionality, sensori-motor gating, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
O'Leary TP; Hussin AT; Gunn RK; Brown RE
Brain Res Bull; 2018 Jun; 140():347-354. PubMed ID: 29870778
[TBL] [Abstract][Full Text] [Related]
2. Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
O'Leary TP; Brown RE
Behav Brain Res; 2009 Jul; 201(1):120-7. PubMed ID: 19428625
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
[TBL] [Abstract][Full Text] [Related]
4. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
[TBL] [Abstract][Full Text] [Related]
5. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
6. [Fundamental study of memory impairment and non-cognitive behavioral alterations in APPswe/PS1dE9 mice].
Taniuchi N; Niidome T; Sugimoto H
Yakugaku Zasshi; 2015; 135(2):323-9. PubMed ID: 25747232
[TBL] [Abstract][Full Text] [Related]
7. Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Stover KR; Brown RE
Behav Brain Res; 2012 May; 231(1):75-85. PubMed ID: 22409975
[TBL] [Abstract][Full Text] [Related]
8. Progressive Spatial Memory Impairment, Brain Amyloid Deposition and Changes in Serum Amyloid Levels as a Function of Age in APPswe/PS1dE9 Mice.
Fu L; Sun Y; Guo Y; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
Curr Alzheimer Res; 2018; 15(11):1053-1061. PubMed ID: 29984654
[TBL] [Abstract][Full Text] [Related]
9. Comparing the effect of the novel ionic cocrystal of lithium salicylate proline (LISPRO) with lithium carbonate and lithium salicylate on memory and behavior in female APPswe/PS1dE9 Alzheimer's mice.
Habib A; Shytle RD; Sawmiller D; Koilraj S; Munna SA; Rongo D; Hou H; Borlongan CV; Currier G; Tan J
J Neurosci Res; 2019 Sep; 97(9):1066-1080. PubMed ID: 31102295
[TBL] [Abstract][Full Text] [Related]
10. Cardiotrophin-1 (CTF1) ameliorates glucose-uptake defects and improves memory and learning deficits in a transgenic mouse model of Alzheimer's disease.
Wang D; Li X; Gao K; Lu D; Zhang X; Ma C; Ye F; Zhang L
Pharmacol Biochem Behav; 2013 Jun; 107():48-57. PubMed ID: 23541490
[TBL] [Abstract][Full Text] [Related]
11. Novel behavioural characteristics of female APPSwe/PS1ΔE9 double transgenic mice.
Cheng D; Low JK; Logge W; Garner B; Karl T
Behav Brain Res; 2014 Mar; 260():111-8. PubMed ID: 24315833
[TBL] [Abstract][Full Text] [Related]
12. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
[TBL] [Abstract][Full Text] [Related]
13. Early β adrenoceptor dependent time window for fear memory persistence in APPswe/PS1dE9 mice.
Karunakaran S
Sci Rep; 2021 Jan; 11(1):870. PubMed ID: 33441593
[TBL] [Abstract][Full Text] [Related]
14. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
[TBL] [Abstract][Full Text] [Related]
15. Early life stress amplifies fear responses and hippocampal synaptic potentiation in the APPswe/PS1dE9 Alzheimer mouse model.
Lesuis SL; Lucassen PJ; Krugers HJ
Neuroscience; 2021 Feb; 454():151-161. PubMed ID: 31302265
[TBL] [Abstract][Full Text] [Related]
16. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Clock Gene Expression and Locomotor Activity Rhythms in Two Month-Old Female APPSwe/PS1dE9 Mice.
Oyegbami O; Collins HM; Pardon MC; Ebling FJP; Heery DM; Moran PM
Curr Alzheimer Res; 2017; 14(8):850-860. PubMed ID: 28317486
[TBL] [Abstract][Full Text] [Related]
18. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
[TBL] [Abstract][Full Text] [Related]
19. Both male and female APPswe/PSEN1dE9 mice are impaired in spatial memory and cognitive flexibility at 9 months of age.
Hulshof LA; Frajmund LA; van Nuijs D; van der Heijden DCN; Middeldorp J; Hol EM
Neurobiol Aging; 2022 May; 113():28-38. PubMed ID: 35294867
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer's Disease.
Petrov D; Luque M; Pedrós I; Ettcheto M; Abad S; Pallàs M; Verdaguer E; Auladell C; Folch J; Camins A
Mol Neurobiol; 2016 Nov; 53(9):6183-6193. PubMed ID: 26558630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
